Proposed Data Collections Submitted for Public Comment and Recommendations, 24044-24045 [05-9066]
Download as PDF
<![CDATA[
24044
Federal Register / Vol. 70, No. 87 / Friday, May 6, 2005 / Notices
Office of Management and Budget
(OMB) a request to review and approve
a renewal of a currently approved
information collection requirement
regarding the GSAR Price Reductions
Clause. A request for public comments
was published at 70 FR 10404, March 3,
2005. No comments were received.
Public comments are particularly
invited on: Whether this collection of
information is necessary and whether it
will have practical utility; whether our
estimate of the public burden of this
collection of information is accurate,
and based on valid assumptions and
methodology; ways to enhance the
quality, utility, and clarity of the
information to be collected.
Submit comments on or before:
June 6, 2005.
DATES:
Ms.
Linda Nelson, Procurement Analyst,
Contract Policy Division, at telephone
(202) 501–1900 or via e-mail to
linda.nelson@gsa.gov.
FOR FURTHER INFORMATION CONTACT:
Submit comments regarding
this burden estimate or any other aspect
of this collection of information,
including suggestions for reducing this
burden to Ms. Jeanette Thornton, GSA
Desk Officer, OMB, Room 10236, NEOB,
Washington, DC 20503, and a copy to
the Regulatory Secretariat (VIR), General
Services Administration, Room 4035,
1800 F Street, NW., Washington, DC
20405. Please cite OMB Control No.
3090–0235, Price Reductions Clause, in
all correspondence.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
A. Purpose
The clause at GSAR 552.238–75, Price
Reductions, used in multiple award
schedule contracts ensures that the
Government maintains its relationship
with the contractor’s customer or
category of customers, upon which the
contract is predicated.
B. Annual Reporting Burden
Number of Respondents: 16,680.
Total Annual Responses: 33,360.
Average hours per response: 7.5
hours.
Total Burden Hours: 250,200.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the General Services Administration,
Regulatory Secretariat (VIR), 1800 F
Street, NW., Room 4035, Washington,
DC 20405, telephone (202) 208–7312.
Please cite OMB Control No. 3090–0235,
Price Reductions Clause, in all
correspondence.
VerDate jul<14>2003
19:51 May 05, 2005
Jkt 205001
Dated: April 29, 2005
Julia Wise,
Director,Contract Policy Division
[FR Doc. 05–9100 Filed 5–5–05; 8:45 am]
BILLING CODE 6820–61–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the National Vaccine
Advisory Committee
Department of Health and
Human Services, Office of the Secretary.
ACTION: Notice.
AGENCY:
SUMMARY: As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (DHHS) is hereby giving notice
that the National Vaccine Advisory
Committee (NVAC) will hold a meeting.
The meeting is open to the public.
DATES: The meeting will be held on June
7, 2005, from 9 a.m. to 5 p.m., and on
June 8, 2005, from 9 a.m. to 3:30 p.m.
ADDRESSES: Department of Health and
Human Services; Hubert H. Humphrey
Building, Room 800; 200 Independence
Avenue, SW., Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT: Ms.
Emma English, Program Analyst,
National Vaccine Program Office,
Department of Health and Human
Services, Room 433–H Hubert H.
Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201;
(202) 690–5566, nvac@osophs.dhhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to Section 2101 of the Public Service
Act (42 U.S.C. Section 300aa–1), the
Secretary of Health and Human Services
was mandated to establish the National
Vaccine Program to achieve optimal
prevention of human infectious diseases
through immunization and to achieve
optimal prevention against adverse
reactions to vaccines. The National
Vaccine Advisory Committee was
established to provide advice and make
recommendations to the Assistant
Secretary for Health, as the Director of
the National Vaccine Program, on
matters related to the program’s
responsibilities.
Topics to be discussed at the meeting
include vaccine supply, adolescent
immunization, influenza, and pandemic
influenza preparedness. New members
will be welcomed to the Committee and
updates will be given by various
subcommittees and working groups. A
tentative agenda will be made available
on or about May 15, 2005, for review on
the NVAC Web site: https://
www.hhs.gov/nvpo/nvac.
Public attendance at the meeting is
limited to space available. Individuals
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
must provide a photo ID for entry into
the Humphrey Building. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
designated contact person. Members of
the public will have the opportunity to
provide comments at the meeting.
Public comment will be limited to five
minutes per speaker. Any members of
the public who wish to have printed
material distributed to NVAC members
should submit materials to the
Executive Secretary, NVAC, through the
contact person listed above prior to
close of business May 31, 2005.
Preregistration is required for both
public attendance and comment. Any
individual who wishes to attend the
meeting and/or participate in the public
comment session should e-mail
nvac@osophs.dhhs.gov.
Dated: May 2, 2005.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. 05–9018 Filed 5–5–05; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–05–05CA]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–371–5983 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
E:\FR\FM\06MYN1.SGM
06MYN1
24045
Federal Register / Vol. 70, No. 87 / Friday, May 6, 2005 / Notices
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Twelve-Month Follow-up of Chronic
Fatigue Syndrome (CFS) and Chronic
Unwellness in Georgia—New —Centers
for Disease Control and Prevention
(CDC)—National Center for Infectious
Diseases (NCID).
Background and Brief Description
The Chronic Fatigue Syndrome
Program within the CDC has been
mandated by Congress to: (1) Estimate
the magnitude of CFS in the United
States with special consideration of
under-served populations (children and
racial/ethnic minorities); (2) describe
the clinical features of CFS; and (3)
additional longitudinal study will allow
CDC to estimate incidence of CFS,
chronic unwellness, and other fatiguerelated illnesses among various racial
and ethnic populations and characterize
the clinical course of these conditions.
CDC will compare prevalence and
incidence estimates from this proposed
study of the Georgia population to
estimates obtained from the longitudinal
Sedgwick County Studies of CFS to
ascertain whether or not findings from
the Sedgwick County Studies can be
generalized to other populations.
The proposed study continues the
initial Georgia survey using similar
methodology and data collection
instruments. This follow-up study will
begin with a detailed telephone
interview to obtain additional data on
participant health status during the last
twelve-month period. Eligible subjects
will be asked to participate in clinical
evaluations. There is no cost to
respondents other than their time. The
total annualized burden hours are 2228.
identify risk factors and diagnostic
markers. CDC is currently planning a
twelve-month follow-up study in
Georgia to estimate the prevalence and
incidence of CFS and other fatiguing
illnesses. The study will also determine
whether or not there are differences in
occurrence of fatiguing illness across
metropolitan, urban, and rural
populations as well as in racial and
ethnic populations.
In 2004, OMB approved the
information collection, Survey of
Chronic Fatigue Syndrome and Chronic
Unwellness in Georgia, under OMB
Number 0920–0638, which provides
baseline information on prolonged
fatiguing illness in selected
metropolitan, urban, and rural regions
in Georgia. Data from the proposed
Follow-up Survey of Chronic Fatigue
Syndrome and Chronic Unwellness in
Georgia, will be added to the baseline
data obtained under OMB Number
0920–0638, which cover the period
September 2004–June 2005. This
ESTIMATE OF ANNUALIZED BURDEN TABLE
Respondents
Number of
respondents
Number
responses per
respondent
Average burden/response
(in hours)
Total burden
hours
Telephone interview .........................................................................................
4,455
1
30/60
2228
Dated: April 29, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 05–9066 Filed 5–5–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–05–05BW]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–371–5983 or send
comments to Seleda Perryman, CDC
Assistant Reports Clearance Officer,
VerDate jul<14>2003
18:03 May 05, 2005
Jkt 205001
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Survey of Primary Care Physicians
Regarding Prostate Cancer Screening—
New—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Prostate cancer is the most common
cancer in men and is the second leading
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
cause of cancer deaths, behind lung
cancer, in the United States. The
American Cancer Society estimates that
there will be about 232,090 new cases
of prostate cancer and about 30,350
deaths in 2005. Although prostate
cancer deaths have declined over the
past several years, it ranks fifth among
deaths from all causes.
The Digital Rectal Examination (DRE)
and Prostate Specific Antigen (PSA) test
are used to screen for prostate cancer.
Screening is controversial and many are
not in agreement as to whether the
potential benefits of screening outweigh
the risks, that is, if PSA based screening,
early detection, and treatment increases
longevity. Although major medical
organizations are divided on whether
men should be routinely screened for
this disease, it appears that all of the
major organizations recommend
discussion with patients about the
benefits and risks of screening.
The purpose of this project is to
develop and administer a national
survey to a sample of American primary
care physicians to examine whether or
not they: (1) Screen for prostate cancer
using PSA and/or DRE, (2) recommend
testing and under what conditions, (3)
discuss the tests and the risks and
benefits of screening with patients, and
E:\FR\FM\06MYN1.SGM
06MYN1
]]>Agencies
[Federal Register Volume 70, Number 87 (Friday, May 6, 2005)]
[Notices]
[Pages 24044-24045]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-9066]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-05-05CA]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-371-5983
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be
[[Page 24045]]
collected; and (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology. Written
comments should be received within 60 days of this notice.
Proposed Project
Twelve-Month Follow-up of Chronic Fatigue Syndrome (CFS) and
Chronic Unwellness in Georgia--New --Centers for Disease Control and
Prevention (CDC)--National Center for Infectious Diseases (NCID).
Background and Brief Description
The Chronic Fatigue Syndrome Program within the CDC has been
mandated by Congress to: (1) Estimate the magnitude of CFS in the
United States with special consideration of under-served populations
(children and racial/ethnic minorities); (2) describe the clinical
features of CFS; and (3) identify risk factors and diagnostic markers.
CDC is currently planning a twelve-month follow-up study in Georgia to
estimate the prevalence and incidence of CFS and other fatiguing
illnesses. The study will also determine whether or not there are
differences in occurrence of fatiguing illness across metropolitan,
urban, and rural populations as well as in racial and ethnic
populations.
In 2004, OMB approved the information collection, Survey of Chronic
Fatigue Syndrome and Chronic Unwellness in Georgia, under OMB Number
0920-0638, which provides baseline information on prolonged fatiguing
illness in selected metropolitan, urban, and rural regions in Georgia.
Data from the proposed Follow-up Survey of Chronic Fatigue Syndrome and
Chronic Unwellness in Georgia, will be added to the baseline data
obtained under OMB Number 0920-0638, which cover the period September
2004-June 2005. This additional longitudinal study will allow CDC to
estimate incidence of CFS, chronic unwellness, and other fatigue-
related illnesses among various racial and ethnic populations and
characterize the clinical course of these conditions. CDC will compare
prevalence and incidence estimates from this proposed study of the
Georgia population to estimates obtained from the longitudinal Sedgwick
County Studies of CFS to ascertain whether or not findings from the
Sedgwick County Studies can be generalized to other populations.
The proposed study continues the initial Georgia survey using
similar methodology and data collection instruments. This follow-up
study will begin with a detailed telephone interview to obtain
additional data on participant health status during the last twelve-
month period. Eligible subjects will be asked to participate in
clinical evaluations. There is no cost to respondents other than their
time. The total annualized burden hours are 2228.
Estimate of Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Number Average burden/
Respondents Number of responses per response (in Total burden
respondents respondent hours) hours
----------------------------------------------------------------------------------------------------------------
Telephone interview......................... 4,455 1 30/60 2228
----------------------------------------------------------------------------------------------------------------
Dated: April 29, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 05-9066 Filed 5-5-05; 8:45 am]
BILLING CODE 4163-18-P
